TY - JOUR
T1 - Furosemide/fludrocortisone test and clinical parameters to diagnose incomplete distal renal tubular acidosis in kidney stone formers
AU - Dhayat, Nasser A.
AU - Gradwell, Michael W.
AU - Pathare, Ganesh
AU - Anderegg, Manuel
AU - Schneider, Lisa
AU - Luethi, David
AU - Mattmann, Cedric
AU - Moe, Orson W.
AU - Vogt, Bruno
AU - Fuster, Daniel G.
N1 - Funding Information:
D.G.F. was supported by the Swiss National Centre of Competence in Research TransCure, the Swiss National Science Foundation (grants # 31003A_135503, 31003A_152829, and 33IC30_166785/1), and by a Medical Research Position Award of the Foundation Prof. Dr. Max Cloëtta. G.P. was supported by the Marie Curie Actions International Fellowship Program. O.W.M. was supported by the National Institutes of Health (P30 DK-079328, R01 DK081423, and T32DK007257), the American Heart Foundation, and the Charles and Jane Pak Foundation.
Publisher Copyright:
© 2017 by the American Society of Nephrology.
PY - 2017/9/7
Y1 - 2017/9/7
N2 - Background and objectives Incomplete distal renal tubular acidosis is a well known cause of calcareous nephrolithiasis but the prevalence is unknown, mostly due to lack of accepted diagnostic tests and criteria. The ammonium chloride test is considered as gold standard for the diagnosis of incomplete distal renal tubular acidosis, but the furosemide/fludrocortisone test was recently proposed as an alternative. Because of the lack of rigorous comparative studies, the validity of the furosemide/fludrocortisone test in stone formers remains unknown. In addition, the performance of conventional, nonprovocative parameters in predicting incomplete distal renal tubular acidosis has not been studied. Design, setting, participants, & measurements We conducted a prospective study in an unselected cohort of 170 stone formers that underwent sequential ammonium chloride and furosemide/fludrocortisone testing. Results Using the ammonium chloride test as gold standard, the prevalence of incomplete distal renal tubular acidosis was 8%. Sensitivity and specificity of the furosemide/fludrocortisone test were 77% and 85%, respectively, yielding a positive predictive value of 30% and a negative predictive value of 98%. Testing of several nonprovocative clinical parameters in the prediction of incomplete distal renal tubular acidosis revealed fasting morning urinary pH and plasma potassium as the most discriminative parameters. The combination of a fasting morning urinarythres hold pH, >5.3with a plasmapot assiumthres hold. >3.8mEq/Lyieldedanegative predictive value of 98% with a sensitivity of 85% and a specificity of 77% for the diagnosis of incomplete distal renal tubular acidosis. Conclusions The furosemide/fludrocortisone test can be used for incomplete distal renal tubular acidosis screening in stone formers, but an abnormal furosemide/fludrocortisone test result needs confirmation by ammonium chloride testing. Our data furthermore indicate that incomplete distal renal tubular acidosis can reliably be excluded in stone formers by use of nonprovocative clinical parameters.
AB - Background and objectives Incomplete distal renal tubular acidosis is a well known cause of calcareous nephrolithiasis but the prevalence is unknown, mostly due to lack of accepted diagnostic tests and criteria. The ammonium chloride test is considered as gold standard for the diagnosis of incomplete distal renal tubular acidosis, but the furosemide/fludrocortisone test was recently proposed as an alternative. Because of the lack of rigorous comparative studies, the validity of the furosemide/fludrocortisone test in stone formers remains unknown. In addition, the performance of conventional, nonprovocative parameters in predicting incomplete distal renal tubular acidosis has not been studied. Design, setting, participants, & measurements We conducted a prospective study in an unselected cohort of 170 stone formers that underwent sequential ammonium chloride and furosemide/fludrocortisone testing. Results Using the ammonium chloride test as gold standard, the prevalence of incomplete distal renal tubular acidosis was 8%. Sensitivity and specificity of the furosemide/fludrocortisone test were 77% and 85%, respectively, yielding a positive predictive value of 30% and a negative predictive value of 98%. Testing of several nonprovocative clinical parameters in the prediction of incomplete distal renal tubular acidosis revealed fasting morning urinary pH and plasma potassium as the most discriminative parameters. The combination of a fasting morning urinarythres hold pH, >5.3with a plasmapot assiumthres hold. >3.8mEq/Lyieldedanegative predictive value of 98% with a sensitivity of 85% and a specificity of 77% for the diagnosis of incomplete distal renal tubular acidosis. Conclusions The furosemide/fludrocortisone test can be used for incomplete distal renal tubular acidosis screening in stone formers, but an abnormal furosemide/fludrocortisone test result needs confirmation by ammonium chloride testing. Our data furthermore indicate that incomplete distal renal tubular acidosis can reliably be excluded in stone formers by use of nonprovocative clinical parameters.
UR - http://www.scopus.com/inward/record.url?scp=85029595360&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029595360&partnerID=8YFLogxK
U2 - 10.2215/CJN.01320217
DO - 10.2215/CJN.01320217
M3 - Article
C2 - 28775126
AN - SCOPUS:85029595360
SN - 1555-9041
VL - 12
SP - 1507
EP - 1517
JO - Clinical Journal of the American Society of Nephrology
JF - Clinical Journal of the American Society of Nephrology
IS - 9
ER -